Health Idea Now
Friday, 1 December 2017
FDA approves Mylan's biosimilar of Roche's cancer drug Herceptin
(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar version of Roche's blockbuster breast cancer treatment Herceptin.
from Reuters: Health News http://ift.tt/2Aw1Nr3
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment